Table 1 Patients pathologic characteristics
Patient characteristics | Median (min, max) |
|---|---|
Age of diagnosis | 48 years (26, 61) |
Tumor size | 5.9 cm (2.5, 11) |
Follow-up period | 6.6 years (2.4, 10.8) |
n (%) | |
|---|---|
ER | |
Negative | 4 (27) |
Positive | 11 (73) |
PR | |
Negative | 4 (27) |
Positive | 11 (73) |
Myometrial invasion | |
Absent | 6 (40) |
Present | 9 (60) |
Lymphovascular invasion | |
Absent | 15 (100) |
Present | 0 (0) |
Sarcomatous overgrowth | |
Absent | 5 (33) |
Present | 10 (67) |
Lymph node involvement | |
No | 15 (100) |
Figo stage overall | |
I | 14 (93) |
II/III/IV | 1 (7) |
Vital status | |
Alive | 10 (67) |
Dead | 5 (33) |
Disease-free survival status | |
Disease-free | 9 (60) |
Disease recurred | 6 (40) |
Local recurrence-free survival status | |
Local recurrence-free | 10 (67) |
Local recurrence | 5 (33) |